Belgium -
English -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
wilfactin 1000 iu/10 ml inj. sol. (pwdr. + solv.) i.v. vial
centrale afdeling voor fractionering - departement central de fractionnement s.p.r.l.-b.v.b.a. - human factor von willebrand 100 iu - powder and solvent for solution for injection - 1000 iu/10 ml - factor von willebrand 100 iu/ml - von willebrand factor
United Arab Emirates -
English -
MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات
wilfactin (100 iu/ ml) 1000 iu/10 ml injection
al ittihad drug store france - 1 glass vial (powder) + 1 glass vial (solvent) + transfer system - injection - 1000 iu/10 ml - cardiovascular system-antifibrinolytics , haemostatics
United Arab Emirates -
English -
MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات
wilfactin (100 iu/ ml) 500 iu/5 ml injection
al ittihad drug store france - 1 glass vial (powder) + 1 glass vial (solvent) + transfer system - injection - 500 iu/5 ml - cardiovascular system-antifibrinolytics , haemostatics
United Arab Emirates -
English -
MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات
wilfactin (100 iu/ ml) 2000 iu/20 ml injection
al ittihad drug store france - 1 glass vial (powder) + 1 glass vial (solvent) + transfer system - injection - 2000 iu/20 ml - cardiovascular system-antifibrinolytics , haemostatics
United Arab Emirates -
English -
MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات
wilfactin (100 iu/ ml) 1000 iu/10 ml
1 glass vial (powder) + 1 glass vial (solvent) + transfer system -
United Arab Emirates -
English -
MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات
wilfactin (100 iu/ ml) 2000 iu/20 ml
1 glass vial (powder) + 1 glass vial (solvent) + transfer system -
United Arab Emirates -
English -
MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات
wilfactin (100 iu/ ml) 500 iu/5 ml
1 glass vial (powder) + 1 glass vial (solvent) + transfer system -
United States -
English -
NLM (National Library of Medicine)
dilantin-125- phenytoin suspension
parke-davis div of pfizer inc - phenytoin (unii: 6158tkw0c5) (phenytoin - unii:6158tkw0c5) - phenytoin 125 mg in 5 ml - dilantin is indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures. dilantin is contraindicated in patients with: - a history of hypersensitivity to phenytoin, its inactive ingredients, or other hydantoins [see warnings and precautions (5.5)]. reactions have included angioedema. - a history of prior acute hepatotoxicity attributable to phenytoin [see warnings and precautions (5.8)]. - coadministration with delavirdine because of the potential for loss of virologic response and possible resistance to delavirdine or to the class of non-nucleoside reverse transcriptase inhibitors. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as dilantin, during pregnancy. physicians are advised to recommend that pregnant patients taking dilantin enroll in the north american antiepileptic drug (naaed) pregnancy registry. this can be done by calling the tollfree number 1-888-233-233